Executive Summary

The global veterinary anti-infectives market is expected to grow at a CAGR of around 5% during the forecast period (2021-2026). The market is driven by the increasing incidence of zoonotic diseases, rising pet ownership, and growing demand for animal-derived products such as meat, milk, and eggs. The market is dominated by key players such as Zoetis Inc., Merck & Co. Inc., and Elanco Animal Health Inc.

Important Note: The companies listed in the image above are for reference only. The final study will cover 18–20 key players in this market, and the list can be adjusted based on our client’s requirements.

Key Market Insights

• The global veterinary anti-infectives market is expected to grow at a CAGR of around 5% during the forecast period (2021-2026).
• The market is driven by the increasing incidence of zoonotic diseases, rising pet ownership, and growing demand for animal-derived products such as meat, milk, and eggs.
• The market is dominated by key players such as Zoetis Inc., Merck & Co. Inc., and Elanco Animal Health Inc.

Market Analysis

The global veterinary anti-infectives market is experiencing steady growth, driven by increasing pet ownership, rising incidence of zoonotic diseases, and growing demand for animal-derived products such as meat, milk, and eggs. The market is expected to reach USD 5.6 billion by 2026, growing at a CAGR of around 5% during the forecast period (2021-2026).

Market Drivers

• Rising pet ownership: The increasing number of pets, especially in developed countries, is driving the demand for veterinary anti-infectives.
• Growing demand for animal-derived products: The growing demand for animal-derived products such as meat, milk, and eggs is driving the demand for veterinary anti-infectives to prevent and treat infections in livestock.
• Increasing incidence of zoonotic diseases: Zoonotic diseases are diseases that can be transmitted from animals to humans. The increasing incidence of zoonotic diseases is driving the demand for veterinary anti-infectives to prevent and treat these diseases in animals.

Market Restraints

• High cost of veterinary drugs: The high cost of veterinary drugs is a major factor restraining the growth of the veterinary anti-infectives market.
• Regulatory issues: The regulatory framework for veterinary drugs is complex, and obtaining regulatory approval can be a lengthy and expensive process. This is a major challenge for companies operating in the veterinary anti-infectives market.

Market Opportunities

• Growing focus on animal health: The growing focus on animal health is creating opportunities for companies operating in the veterinary anti-infectives market. Pet owners and livestock farmers are increasingly willing to spend money on preventative healthcare for their animals.
• Increasing demand for generic drugs: The increasing demand for generic drugs is creating opportunities for companies operating in the veterinary anti-infectives market. Generic drugs are less expensive than branded drugs and offer similar therapeutic effects.

Market Dynamics

The global veterinary anti-infectives market is highly competitive, with a few large players dominating the market. Key players in the market include Zoetis Inc., Merck & Co. Inc., and Elanco Animal Health Inc. These companies are investing heavily in research and development to introduce new and innovative products that cater to the changing needs of customers.

Regional Analysis

North America dominates the global veterinary anti-infectives market, followed by Europe and Asia Pacific. The high adoption of pets in North America, coupled with the growing demand for animal-derived products, is driving the demand for veterinary anti-infectives in the region.

Competitive Landscape

Leading companies in the Veterinary Anti-infectives Market:

1. Zoetis Inc.
2. Merck Animal Health (Merck & Co., Inc.)
3. Boehringer Ingelheim International GmbH
4. Elanco Animal Health Incorporated (Eli Lilly and Company)
5. Bayer AG
6. Ceva Santé Animale
7. Vetoquinol S.A.
8. Virbac
9. Dechra Pharmaceuticals PLC
10. Neogen Corporation

Please note: This is a preliminary list; the final study will feature 18–20 leading companies in this market. The selection of companies in the final report can be customized based on our client’s specific requirements.

Segmentation

The global veterinary anti-infectives market can be segmented by product type, animal type, and geography. By product type, the market can be segmented into antibiotics, antivirals, antifungals, and others. By animal type, the market can be segmented into companion animals and livestock.

Category-wise Insights

• Antibiotics are the most commonly used veterinary anti-infectives, accounting for the largest share of the market.
• Companion animals are the largest segment of the market, driven by the growing adoption of pets in developed countries.

Key Benefits for Industry Participants and Stakeholders

• The growing demand for veterinary anti-infectives is creating opportunities for companies operating in the market.
• The increasing focus on animal health is driving the demand for veterinary anti-infectives.
• The increasing demand for generic drugs is creating opportunities for companies operating in the market.

SWOT Analysis

Strengths:

• Strong demand for veterinary anti-infectives due to the growing adoption of pets and the increasing demand for animal-derived products
• High level of investment in research and development by key players

Weaknesses:

• High cost of veterinary drugs
• Regulatory issues and the complex regulatory framework for veterinary drugs

Opportunities:

• Growing focus on animal health
• Increasing demand for generic drugs

Threats:

• Competition from new entrants
• The potential emergence of antibiotic-resistant bacteria

Market Key Trends

• Increasing demand for antibiotics and antivirals due to the rising incidence of bacterial and viral infections in animals
• Growing preference for generic drugs over branded drugs due to their cost-effectiveness
• Increasing adoption of companion animals, especially in developed countries

Covid-19 Impact

The Covid-19 pandemic has had a mixed impact on the global veterinary anti-infectives market. On the one hand, the pandemic has led to a decline in the adoption of pets in some countries due to economic uncertainty. On the other hand, the pandemic has led to an increase in the demand for animal-derived products such as meat and eggs, which has driven the demand for veterinary anti-infectives.

Key Industry Developments

• In 2021, Zoetis Inc. announced the launch of a new antibiotic for the treatment of skin infections in dogs.
• In 2020, Elanco Animal Health Inc. completed its acquisition of Bayer Animal Health, making it one of the largest players in the veterinary anti-infectives market.

Analyst Suggestions

• Companies operating in the veterinary anti-infectives market should focus on investing in research and development to introduce new and innovative products that cater to the changing needs of customers.
• Companies should also focus on expanding their product portfolios and strengthening their distribution networks to increase their market share.

Future Outlook

The global veterinary anti-infectives market is expected to continue its steady growth during the forecast period (2021-2026), driven by increasing pet ownership, rising incidence of zoonotic diseases, and growing demand for animal-derived products such as meat, milk, and eggs.